Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Brugmann University Hospital

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1923-01-01

Employees: -

Market Cap: -

Website: http://www.chu-brugmann.be/en

Clinical Trials

Short- and Long-term Health Adverse Outcomes Associated With Nutrition Disorders and Nutrition Related Conditions in Hospitalized Older People

Conditions: Nutrition Disorders

First Posted Date: 2022-03-11

Last Posted Date: 2022-03-11

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 224

Registration Number: NCT05276752

Locations: 🇧🇪
CHU Brugmann, Brussels, Belgium

Investigation of Cerebral Motor Activity Modulations Following Median Nerve Stimulation During General Anaesthesia

Early Phase 1

Recruiting

Conditions: Accidental Awareness During General Anesthesia

Interventions: Drug: Propofol
Device: Median nerve stimulation
Device: EEG measurements

First Posted Date: 2022-03-09

Last Posted Date: 2023-02-16

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 30

Registration Number: NCT05272202

Locations: 🇧🇪
CHU Brugmann, Brussels, Belgium

Study Comparing Dural Puncture Epidural With Epidural and Combined Spinal Epidural Anesthesia for Obstetric Analgesia.

Phase 3

Conditions: Analgesia
Obstetric Pain

Interventions: Procedure: Dural puncture
Procedure: Epidural analgesia
Procedure: Combined spinal epidural analgesia
Drug: Sufentanyl/Levobupivacaine

First Posted Date: 2022-01-19

Last Posted Date: 2022-02-24

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 90

Registration Number: NCT05196256

Locations: 🇧🇪
CHU Brugmann, Brussels, Belgium

Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging

Phase 3

Conditions: Pediatric Sedation
MRI
Midazolam
Dexmedetomidine

Interventions: Drug: Midazolam
Drug: Dexmedetomidine

First Posted Date: 2022-01-14

Last Posted Date: 2022-03-24

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 250

Registration Number: NCT05192629

Locations: 🇧🇪
Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium

Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire

Completed

Conditions: Peripartum Period
HEMSTOP Questionnaire
Hemorrhage

Interventions: Diagnostic Test: HEMSTOP questionnaire

First Posted Date: 2022-01-13

Last Posted Date: 2022-07-20

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 3588

Registration Number: NCT05191251

Locations: 🇧🇪
CHU Brugmann, Brussels, Belgium

Influence of Timing of Switch Operation in Transposition of Great Arteries

Completed

Conditions: Transposition of Great Vessels

First Posted Date: 2021-12-16

Last Posted Date: 2022-07-20

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 151

Registration Number: NCT05160116

Locations: 🇧🇪
Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium

Influence of Intraoperative Fluid Balance on the Incidence of Adverse Events in Pediatric Cardiac Surgery

Completed

Conditions: Congenital Heart Disease in Children
Surgery
Fluid Overload

Interventions: Drug: Fluid balance

First Posted Date: 2021-12-02

Last Posted Date: 2022-07-20

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 1400

Registration Number: NCT05142046

Locations: 🇧🇪
Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium

tDCS to Prevent Relapse in Alcohol Use Disorder

Not Applicable

Completed

Conditions: Sham tDCS
Active tDCS

Interventions: Device: tDCS

First Posted Date: 2021-08-04

Last Posted Date: 2022-09-29

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 40

Registration Number: NCT04990375

Locations: 🇧🇪
CHU-Brugmann, Brussels, Belgium

Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.

Completed

Conditions: Macular Degeneration

First Posted Date: 2021-08-03

Last Posted Date: 2022-03-21

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 34

Registration Number: NCT04988178

Locations: 🇧🇪
CHU Brugmann, Brussels, Belgium

Perioperative Transfusion Strategies in Adult Congenital Heart Disease Patients Undergoing Cardiac Surgery

Conditions: Cardiac Surgery
Congenital Heart Disease
Morbidity, Multiple
Blood Transfusion

First Posted Date: 2021-07-22

Last Posted Date: 2022-04-01

Lead Sponsor: Brugmann University Hospital

Target Recruit Count: 500

Registration Number: NCT04973514

Locations: 🇧🇪
CHU Brugmann, Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy